What are the key trends in the global Cell Viability Assays Market?
Cell
Viability Assays Market Highlights
The
imperative factor driving the global cell viability assays market growth is the
growing prevalence of chronic ailments and infectious diseases. Other important
factors aiding the market growth include growing availability of funds for
cell-based research, increasing focus on developing cell-based therapeutics,
and the rising need of cell-based assays in research and development (R&D)
activities.
Cell Viability Assays Market Overview and analysis by product, cell type, application, end-user,
forecast till 2030. Cell viability assays is a type of technique that is used
for determining viable cells in the culture. Market Research Future (MRFR) has
published a research report about the global cell viability assays market is
anticipated to reach USD 3.83 billion by 2030 at 8.50% CAGR during the forecast
period 2022-2030.
Market
Regional Analysis
The
regional segmentation of the global cell viability assays market insights has segmented the global market into regional
markets known as the Asia Pacific, The Americas (North America & South
America), Europe, and the Middle East & Africa (MEA). During the forecast
period, North America has been estimated to hold the largest market share in
the global market. In this region, the market has been anticipated to grow due
to technological advancement, the presence of many key market players, the high
purchasing power of consumers, and more and more people owning cell viability
assays. The relevant country-specific markets in this region are USA, Canada,
and Mexico. Due to technological advancement, medical facilities, and
purchasing power of people being lower than North America, South America is a
comparatively smaller regional market. The two strongest economies that have
the potential to emerge as suitable markets are Argentina and Brazil.
During
the forecast period, Europe is expected to hold the second largest position in
the global market. The market growth in this region has been attributed to the
increasing healthcare expenditure, the presence of many key market players, and
the growing prevalence of chronic ailments. Due to the reasons same as the
Americas, Western Europe is a bigger market than Eastern Europe. In Europe, the
major country-specific markets are France, Germany, Italy, Spain, and the UK,
followed by the remaining countries of Western Europe and Eastern Europe.
During
the forecast period, the market in Asia Pacific region is expected to emerge as
the fastest growing during the assessment period due to a rising number of
genomics, proteomics, and stem cell research activities. Increased funding in
the research activities by pharmaceutical & biotechnology companies is also
boosting the market growth. In this region, the most important country-specific
markets are Australia, China, India, Japan, and South Korea, followed by the
remaining countries of the Asia Pacific region.
The MEA
region holds the smallest market share in the global market. In this region,
the market is small and limited due to poor countries, lack of awareness, lack
of advanced medical facilities, low standard of medical facilities, lack of
education, lack of healthcare facilities, and most governments not considering
healthcare a priority.
Market
Segmentation
The
global cell viability assays market segmentation has segmented the market into
applications, cell type, end user, products, and lastly, region. The
application-based segmentation segments this market into clinical &
diagnostic applications, drug discovery & development, stem cell research, and
others. By cell type, the market has been segmented into animal cells, human
cells, and microbial cells. Based on the end users, the market has been
segmented into academic & research institutes, hospital & diagnostic
laboratories, pharmaceutical & biotechnology companies, and others.
Based
on products, the market has been segmented into consumables and instruments.
Consumables have been sub-segmented into assay kits, microplates, and reagents.
The assay kits have been further segmented into calcein-Am cell viability
assays kits, resazurin cell viability assays kits, tetrazolium reduction assay
kits, and other assay kits. The tetrazolium assay kits have been further
segmented into MTT assay kits and other tetrazolium assay kits. Instruments
have been sub-segmented into automated cell counters, cell imaging &
analysis systems, flow cytometers, and spectrophotometers.
Key
Players
The key
players in the cell viability assays market include Abcam PLC (UK), Becton
Dickinson and Company (USA), Biotek Instruments (USA), Bio-Rad Laboratories
(USA), Biotium (USA), Creative Bioarray (USA), Danaher Corporation (USA),
GE Healthcare (USA), Merck KGaA (Germany), PerkinElmer (USA), Promega
Corporation (USA), and Thermo Fisher Scientific (USA).
Latest
Industry News
- iSpecimen®
has introduced a full range of fresh primary viable cells for life science
and cell therapy researchers. 23 JAN 2019
- DeNovix
Inc. has launched the CellDrop Automated Cell Counter. This is the first
instrument to incorporate DeNovix’ patent pending DirectPipette™
Technology, removing the need for environmentally damaging and expensive
plastic slides. 23 JAN 2019
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment